162 related articles for article (PubMed ID: 36466999)
1. Deferiprone-Resveratrol Hybrid, an Iron-Chelating Compound, Acts as an Antimalarial and Hepatoprotective Agent in
Chuljerm H; Maneekesorn S; Punsawad C; Somsak V; Ma Y; Ruangsuriya J; Srichairatanakool S; Koonyosying P
Bioinorg Chem Appl; 2022; 2022():3869337. PubMed ID: 36466999
[TBL] [Abstract][Full Text] [Related]
2. Anti-Malarial and Anti-Lipid Peroxidation Activities of Deferiprone-Resveratrol Hybrid in
Chuljerm H; Maneekesorn S; Somsak V; Ma Y; Srichairatanakool S; Koonyosying P
Biology (Basel); 2021 Sep; 10(9):. PubMed ID: 34571788
[TBL] [Abstract][Full Text] [Related]
3. Deferiprone-resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells.
Li J; Koonyosying P; Korsieporn W; Paradee N; Hutachok N; Xu H; Ma Y; Chuljerm H; Srichairatanakool S
Front Mol Biosci; 2024; 11():1364261. PubMed ID: 38572444
[TBL] [Abstract][Full Text] [Related]
4. Identifying a Deferiprone-Resveratrol Hybrid as an Effective Lipophilic Anti-Plasmodial Agent.
Maneekesorn S; Chuljerm H; Koonyosying P; Uthaipibull C; Ma Y; Srichairatanakool S
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279413
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol ameliorates methotrexate-induced hepatotoxicity in rats via inhibition of lipid peroxidation.
Dalaklioglu S; Genc GE; Aksoy NH; Akcit F; Gumuslu S
Hum Exp Toxicol; 2013 Jun; 32(6):662-71. PubMed ID: 23424212
[TBL] [Abstract][Full Text] [Related]
6. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
Koonyosying P; Kongkarnka S; Uthaipibull C; Svasti S; Fucharoen S; Srichairatanakool S
Biomed Pharmacother; 2018 Dec; 108():1694-1702. PubMed ID: 30372872
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice.
Thephinlap C; Phisalaphong C; Fucharoen S; Porter JB; Srichairatanakool S
Med Chem; 2009 Sep; 5(5):474-82. PubMed ID: 19534681
[TBL] [Abstract][Full Text] [Related]
8. The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.
Song D; Zhao L; Li Y; Hadziahmetovic M; Song Y; Connelly J; Spino M; Dunaief JL
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4525-32. PubMed ID: 24970260
[TBL] [Abstract][Full Text] [Related]
9. Comparative antimalarial, toxicity and mito-protective effects of Diospyros mespiliformis Hochst. ex A. DC. and Mondia whitei (Hook.f.) Skeels on Plasmodium berghei infection in mice.
Olanlokun JO; Bodede O; Prinsloo G; Olorunsogo OO
J Ethnopharmacol; 2021 Mar; 268():113585. PubMed ID: 33189839
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of malaria liver pathology in mice infected with Plasmodium chabaudi AS or Plasmodium berghei NK65.
Scaccabarozzi D; Deroost K; Corbett Y; Lays N; Corsetto P; Salè FO; Van den Steen PE; Taramelli D
Malar J; 2018 Jan; 17(1):18. PubMed ID: 29316914
[TBL] [Abstract][Full Text] [Related]
11. Iron-overload-induced ferroptosis in mouse cerebral toxoplasmosis promotes brain injury and could be inhibited by Deferiprone.
Wang C; Xie L; Xing Y; Liu M; Yang J; Gao N; Cai Y
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011607. PubMed ID: 37651502
[TBL] [Abstract][Full Text] [Related]
12. The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.
Hadziahmetovic M; Song Y; Wolkow N; Iacovelli J; Grieco S; Lee J; Lyubarsky A; Pratico D; Connelly J; Spino M; Harris ZL; Dunaief JL
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):959-68. PubMed ID: 21051716
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina.
Song D; Song Y; Hadziahmetovic M; Zhong Y; Dunaief JL
Free Radic Biol Med; 2012 Jul; 53(1):64-71. PubMed ID: 22579919
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections.
Wood PA; Eaton JW
Am J Trop Med Hyg; 1993 Apr; 48(4):465-72. PubMed ID: 8480854
[TBL] [Abstract][Full Text] [Related]
15. Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.
De-Oliveira AC; Carvalho RS; Paixão FH; Tavares HS; Gueiros LS; Siqueira CM; Paumgartten FJ
Malar J; 2010 Mar; 9():81. PubMed ID: 20307316
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspective.
Bentley A; Gillard S; Spino M; Connelly J; Tricta F
Pharmacoeconomics; 2013 Sep; 31(9):807-22. PubMed ID: 23868464
[TBL] [Abstract][Full Text] [Related]
17. Iron chelation by deferiprone does not rescue the Niemann-Pick Disease Type C1 mouse model.
Hung YH; Lotan A; Yeshurun S; Schroeder A; Bush AI
Biometals; 2020 Jun; 33(2-3):87-95. PubMed ID: 32100150
[TBL] [Abstract][Full Text] [Related]
18. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic and safety profile of single-dose deferiprone in subjects with sickle cell disease.
Soulières D; Mercier-Ross J; Fradette C; Rozova A; Tsang YC; Tricta F
Ann Hematol; 2022 Mar; 101(3):533-539. PubMed ID: 34981144
[TBL] [Abstract][Full Text] [Related]
20. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
Konziase B
J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
